Coronary Artery Bypass Graft Companies

Dec 2023Edwards Lifesciences (US) received FDA approval for their transcatheter aortic valve replacement (TAVR) therapy as a treatment option for certain patients with severe aortic stenosis who are deemed high-risk for CABG.Continued advancements in their minimally invasive heart valve technologies, potentially impacting the choice of procedures for some patients who would traditionally undergo CABG.

Medtronic launched their Hugo™ robotic-assisted surgery system designed specifically for minimally invasive cardiac and thoracic procedures, including CABG.Developed their Tiara™ off-pump coronary bypass system with improved maneuverability and visualization for surgeons performing minimally invasive CABG.

Stryker Corporation (US) introduced their Aortica® Ascending Aortic Aortic Arch Hybrid Graft device for complex aortic procedures sometimes requiring concomitant CABG surgery.Focused on developing innovative vascular closure devices to minimize bleeding complications after CABG procedures.

Terumo Corporation (Japan) received CE Mark approval for their HEMACORE® Coronary Bypass Perfusion System, offering improved temperature control and organ protection during CABG surgery.Partnered with medical institutions to implement their minimally invasive bypass techniques and improve patient outcomes.

Maquet Getinge Group (Germany) expanded their portfolio of advanced bypass grafts with biocompatible materials and extended durability, promoting long-term graft function.Developed innovative perfusion cannulas for improved blood flow management during CABG surgery, reducing surgical risks.

List of Coronary Artery Bypass Graft Key Companies in the Market

• Hancock Jaffe Laboratories, Inc.


• VasoPrep Surgical


• Dextera Surgical Inc.


• Neograft Inc.


• Terumo Cardiovascular Systems Corporation


• NOVADAQ Technologies Inc.


• MAQUET Holding B.V. & Co. KG.


• Genesee BioMedical


• Sorin Group


• Boston Scientific


• Edwards Lifesciences Corporation


• Others